Many dropouts are not decisions to quit the science; they are decisions to stop making the trip. A traditional trial asks participants to come to a site repeatedly, often for measurements that take only a few minutes once they arrive. The journey, the waiting, and the time away from work or family are the real cost. Remote participation changes that balance. A video visit can replace some in-person check-ups, and a wearable can record measurements continuously at home instead of during a brief clinic appointment. For the trial, this means fewer missed visits, because a visit that does not require travel is harder to miss. It can also mean richer data, since a device worn over days captures more than a single snapshot. The trade-off is real: remote measurements must be reliable, participants must be able to use the devices, and some assessments still need a clinic. But where remote participation is appropriate, it removes one of the most common reasons people leave.
Learn MotionHow AI Makes Clinical Trials Faster: A High-Level Overview
Keeping Participants in the Trial
Taking the Burden Out of Taking Part
4 / 4
Compare the two sides. On the left, the traditional path: repeated trips to a site, each one costing travel, waiting, and time away from normal life, all for a measurement that might take minutes. On the right, the remote path: a video visit replaces some of those trips, and a wearable records measurements at home, continuously, without anyone travelling. The effect on retention is direct. A visit that does not require a journey is much harder to miss, so fewer visits are lost. And the data can be richer, because a device worn for days sees more than a single clinic snapshot. But be honest about the trade-offs: remote measurements have to be reliable, participants have to be able to use the devices, and some assessments still genuinely need a clinic. Where it fits, though, it removes one of the biggest reasons people leave.
0:00 / 0:00